Mahfoud, FelixFelixMahfoudMancia, GiuseppeGiuseppeManciaSchmieder, Roland ERoland ESchmiederRuilope, LuisLuisRuilopeNarkiewicz, KrzysztofKrzysztofNarkiewiczSchlaich, MarkusMarkusSchlaichWilliams, BryanBryanWilliamsRibichini, FlavioFlavioRibichiniWeil, JoachimJoachimWeilHSIEN-LI KAORodriguez-Leor, OriolOriolRodriguez-LeorNoory, EliasEliasNooryOng, Tiong KiamTiong KiamOngUnterseeh, ThierryThierryUnterseehde Araújo Gonçalves, PedroPedrode Araújo GonçalvesZirlik, AndreasAndreasZirlikAlmerri, KhaledKhaledAlmerriSharif, FaisalFaisalSharifLauder, LucasLucasLauderWanten, MarianneMarianneWantenFahy, MartinMartinFahyBöhm, MichaelMichaelBöhm2023-03-092023-03-092022-11-150735-1097https://scholars.lib.ntu.edu.tw/handle/123456789/629100Renal denervation (RDN) has been shown to lower blood pressure (BP), but its effects on cardiovascular events have only been preliminarily evaluated. Time in therapeutic range (TTR) of BP is associated with cardiovascular events.encardiovascular death; hypertension; myocardial infarction; risk reduction; strokeCardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Rangejournal article10.1016/j.jacc.2022.08.802363570872-s2.0-85140985282WOS:000931948500006https://api.elsevier.com/content/abstract/scopus_id/85140985282